Acute Erythroblastic Leukemia

Search Trials
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
Status:
Completed
Last Changed:
May 3, 2013
First Changed:
Jul 27, 2006
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
vorinostatcytarabineetoposidepharmacological studylaboratory biomarker analysis
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
Status:
Completed
Last Changed:
May 6, 2010
First Changed:
Feb 17, 2006
Disease(s):
Chronic Myeloproliferative Disorders
Intervention(s):
clofarabinecyclophosphamide
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Status:
Completed
Last Changed:
Jun 27, 2013
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
asparaginasecytarabinedaunorubicin hydrochloridemethotrexatetherapeutic hydrocortisonethioguanine
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
Status:
Completed
Last Changed:
Feb 11, 2013
First Changed:
Jun 14, 2005
Disease(s):
Chronic Myeloproliferative Disorders
Intervention(s):
decitabineromidepsin

Connect. Empower. Inspire.